Endologix clinical trials
Part of Deerfield Management.
The registry lists 35 studies whose lead sponsor is Endologix or one of 1 company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 9, 2026.
Our grouping of 2 registry names, not the registry’s. See them and correct one ↓
- 35studies on the registry
- 2open to participants now
- 1reach primary completion within a year
Get an email when these change. Save the Endologix studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
1 of Endologix’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- 1MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
The study
- May 2027The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 SystemNCT06990048
Add it to your calendar (.ics) → With an account.
All 35 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 08
- 09
- 10
- 11
- 12
- 513
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 2 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Endologix.
- Endologix25 studiesSame company
Something wrong?
- 10 studies →
Focus areas
Conditions Endologix leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 35 of 35.
- JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through RandomizationRecruitingNCT05064540Not applicable
- The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)Enrolling by invitationNCT06315023
- The PQ Bypass Pivotal IDE Intra-arterial Stent Graft StudyCompletedNCT04130737Not applicable
- Nellix Registry Study: EVAS-GlobalCompletedNCT02996396
- DETOUR I Clinical Study for Percutaneous Femoropopliteal BypassCompletedNCT02471638Not applicable
- EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory StudyCompletedNCT03298477Not applicable
- The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 SystemActive, not recruitingNCT06990048
- Nellix® Registry Study: EVAS-GlobalCompletedNCT02018744
- Chimney EndoVascular Aneurysm Sealing Of New Expanded IndicationActive, not recruitingNCT04252573Not applicable
- TORUS I Clinical StudyCompletedNCT03128424Not applicable
- JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through RandomizationWithdrawnNCT05409118Not applicable
- The DETOUR 2 Clinical TrialCompletedNCT03119233Not applicable
- Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® SystemCompletedNCT01726257Not applicable
- Detour2 Continued Access StudyCompletedNCT04625660Not applicable
- Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR DevicesCompletedNCT02407457Not applicable
- PQ Bypass Guide Wire Delivery System for Femoropopliteal BypassCompletedNCT01930071Not applicable
- Pilot Study of the Endologix Fenestrated Stent Graft SystemCompletedNCT01437215Not applicable
- Percutaneous Endovascular Aneurysm Repair (PEVAR) TrialCompletedNCT01070069Not applicable
- Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) StudyCompletedNCT02949297Not applicable
- Clinical Study of the TriVascular Ovation™ Abdominal Stent Graft SystemCompletedNCT01092117Not applicable
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic AneurysmCompletedNCT00739401Not applicable
- 34mm Cuff Study for Endovascular Repair of Abdominal Aortic AneurysmsCompletedNCT00706394Not applicable
- Feasibility and Safety Study of the Endologix Fenestrated Stent Graft SystemCompletedNCT01348828Not applicable
- Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft SystemCompletedNCT01491945Not applicable
- Powerlink Bifurcated Stent Graft Long-Term Follow-up StudyCompletedNCT00543270Not applicable
- LIFE Study: Least Invasive Fast-Track EVARCompletedNCT02224794
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair in EuropeCompletedNCT02703428
Sponsor listed in the registry: TriVascular, Inc. · First submitted after TriVascular, Inc. became part of Endologix
- TriVascular Canadian LIFE Study: Least Invasive Fast-Track EVAR (Endovascular Aneurysm Repair)CompletedNCT02451566
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- Post-Approval Study of the Ovation™/Ovation Prime™ Abdominal Stent Graft SystemCompletedNCT01980901
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- TriVascular European Union (EU) Abdominal Stent Graft TrialCompletedNCT01097772Not applicable
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- TriVascular Post-Market RegistryCompletedNCT01372709
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- South American Abdominal Stent Graft TrialCompletedNCT01082185Phase 1
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- LUCY Study: TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm RepairCompletedNCT02479191
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix
- The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic AneurysmsCompletedNCT02048514Not applicable
- South American Thoracic Stent-Graft StudyCompletedNCT01082172Not applicable
Sponsor listed in the registry: TriVascular, Inc. · First submitted before TriVascular, Inc. became part of Endologix